Celularity Inc.

Anthrogenesis Corporation

Kathy Karasiewicz-Mendez

Xiaokui Zhang

Stewart Abbot

Robert J Hariri

Vanessa R Voskinarian-Berse

Eric Law

Vladimir Jankovic

Jennifer Paredes

Allan Reduta

Andrew Morschauser

Ivana Djuretic

Aleksander Francki

Provided herein are compositions of placenta-derived adherent cell exosomes and methods of making and using the same. In one aspect, provided herein are compositions comprising exosomes produced by and/or derived from placental cells, e.g., placenta-derived adherent cells. In certain embodiments, the exosomes provided herein are produced by placenta-derived adherent cells that have been cultured in vitro for, e.g., 1, 2, 3, 4, 5, 6 or more passages.

Placenta-derived adherent cell exosomes and uses thereof

Provided herein are placental stem cells that exhibit increased survival ('enhanced placental stem cells'), compositions comprising such placental stem cells, and methods of using such placental stem cells and compositions.

Enhanced placental stem cells and uses thereof

Provided herein are methods of producing enhanced placental stem cells by modulatory RNA molecules. Also provided herein are methods of using enhanced placental stem cells, for example, to treat individuals having a disease, disorder or condition caused by, or relating to, an unwanted or harmful immune response. Further provided herein are compositions comprising said enhanced placental stem cells.

Enhancement of placental stem cell potency using modulatory RNA molecules

Growing community of inventors

Hillsborough, NJ, United States of America

Kathy Karasiewicz-Mendez